1
|
de Lima Damasceno BDG, de Melo DF, Guedes GG, de Carvalho Moreira LMC, Oshiro-Júnior JA. Physicochemical Characterization Of Silver Sulfadiazine In Polymeric Wound Dressings. Curr Pharm Des 2023; 29:865-882. [DOI: 10.2174/1381612829666230324122925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 01/05/2023] [Accepted: 01/24/2023] [Indexed: 03/29/2023]
Abstract
Background:
The insertion of topical antimicrobials in wound treatment represented an important role in patient management. Among these agents, silver sulfadiazine (AgSD), introduced in the therapy of wounds and burns in the 1960s, is considered the gold standard in treatment due to its mechanism of action, in addition to its proven efficacy and safety. The association of AgSD with polymers for the development of curative formulations has been reported. The evaluation of the physical-chemical properties of these systems with the aid of analytical techniques of characterization is essential for the determination of their activities, besides allowing the detection of possible incompatibilities between AgSD and polymers.
Objective:
Thus, this review presents the main techniques of physicochemical characterization used in the evaluation of systems containing AgSD with curative purposes in order to provide parameters to ensure the efficacy and safety of these new therapeutic options.
Results:
Microscopic, thermoanalytical, and spectroscopic techniques, for example, provide information on system properties such as surface chemical composition, crystallinity, morphology, and thermal stability of curative formulations containing AgSD.
Conclusion:
These techniques are important in the selection of the most appropriate techniques during the development of a polymeric curative system containing AgSD, in addition to providing information for cost reduction of a possible scale-up and the establishment of methodologies for quality control of these systems to ensure their efficacy and safety.
Collapse
|
2
|
Ivyna de Araújo Rêgo R, Guedes Silvestre GF, Ferreira de Melo D, Albino SL, Pimentel MM, Silva Costa Cruz SB, Silva Wurzba SD, Rodrigues WF, Goulart de Lima Damasceno BP, Cançado Castellano LR. Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer. Front Pharmacol 2022; 13:951125. [PMID: 36120379 PMCID: PMC9470917 DOI: 10.3389/fphar.2022.951125] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Accepted: 06/20/2022] [Indexed: 11/15/2022] Open
Abstract
Gastric cancer is the fifth most common and fourth type to cause the highest mortality rates worldwide. The leading cause is related to Helicobacter pylori (H. pylori) infection. Unfortunately, current treatments have low success rates, highlighting the need for alternative treatments against carcinogenic agents, specifically H. pylori. Noteworthy, natural origin products contain pharmacologically active metabolites such as flavonoids, with potential antimicrobial applications. Objective: This article overviews flavonoid-rich extracts’ biological and pharmacological activities. It focuses on using these substances against Helicobacter pylori infection to prevent gastric cancer. For this, PubMed and Science Direct databases were searched for studies that reported the activity of flavonoids against H. pylori, published within a 10-year time frame (2010 to August 2020). It resulted in 1,773 publications, of which 44 were selected according to the search criteria. The plant family primarily found in publications was Fabaceae (9.61%). Among the flavonoids identified after extraction, the most prevalent were quercetin (19.61%), catechin (13.72), epicatechin (11.76), and rutin (11.76). The potential mechanisms associated with anti-H. pylori activity to the extracts were: inhibition of urease, damage to genetic material, inhibition of protein synthesis, and adhesion of the microorganism to host cells. Conclusion: Plant extracts rich in flavonoids with anti-H. pylori potential proved to be a promising alternative therapy source, reinforcing the relevance of studies with natural products.
Collapse
Affiliation(s)
- Renaly Ivyna de Araújo Rêgo
- Human Immunology Research and Education Group-GEPIH, Federal University of Paraiba, João Pessoa, Brazil
- Postgraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Brazil
- Postgraduate Program of Science and Technology in Health, State University of Paraíba, Campina Grande, Brazil
| | | | - Demis Ferreira de Melo
- Postgraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Brazil
| | - Sonaly Lima Albino
- Postgraduate Program of Therapeutic Innovation, Federal University of Pernambuco, Recife, Brazil
| | - Marcela Monteiro Pimentel
- Postgraduate Program of Science and Technology in Health, State University of Paraíba, Campina Grande, Brazil
| | - Sara Brito Silva Costa Cruz
- Postgraduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Brazil
- Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC, Canada
- Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Faculty of Medicine, McGill University, Montreal, QC, Canada
| | - Sabrina Daniela Silva Wurzba
- Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC, Canada
- Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Faculty of Medicine, McGill University, Montreal, QC, Canada
| | | | | | - Lúcio Roberto Cançado Castellano
- Human Immunology Research and Education Group-GEPIH, Federal University of Paraiba, João Pessoa, Brazil
- Postgraduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Brazil
- Postgraduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Brazil
- Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC, Canada
- Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Faculty of Medicine, McGill University, Montreal, QC, Canada
- *Correspondence: Lúcio Roberto Cançado Castellano,
| |
Collapse
|
3
|
de Assis ACL, Moreira LMCDC, Rocha BP, Pereira MRB, de Melo DF, de Moura RO, de Azevedo EP, Oshiro-Junior JA, Damasceno BPGDL. N-acylhydrazone Derivative-Loaded Cellulose Acetate Films: Thermoanalytical, Spectroscopic, Mechanical and Morphological Characterization. Polymers (Basel) 2021; 13:polym13142345. [PMID: 34301102 PMCID: PMC8309645 DOI: 10.3390/polym13142345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 07/12/2021] [Accepted: 07/14/2021] [Indexed: 12/20/2022] Open
Abstract
Cellulose acetate (ACT) is one of the most important cellulose derivatives due to its biodegradability and low toxicity, presenting itself as one of the main substitutes for synthetic materials in the development of wound dressing films. The incorporation of a N-acylhydrazonic derivative (JR19), with its promising anti-inflammatory activity, may represent an alternative for the treatment of skin wounds. This work aims to develop and to physicochemically and mechanically characterize ACT films containing JR19. The films were prepared using the ‘casting’ method and further characterized by thermoanalytical and spectroscopic techniques. In addition, mechanical tests and morphological analysis were performed. Thermogravimetry (TG) and differential scanning calorimetry (DSC) analyses showed that the thermal events attributed to excipients and films were similar, indicating the absence of physical incompatibilities between ACT and JR19. Infrared spectroscopy showed that JR19 was incorporated into ACT films. The characteristic band attributed to C≡N (2279 to 2264 cm−1) was observed in the spectra of JR19, in that of the physical mixture of JR19/ACT, and, to a lesser extent, in the spectra of JR19 incorporated into the ACT film, suggesting some interaction between JR19 and ACT. X-ray diffraction (XRD) evidenced the suppression of the crystallinity of JR19 (diffraction peaks at 8.54°, 12.80°, 14.09°, 16.08°, 18.19°, 22.65°, 23.59°, 24.53°, 25.70°, 28.16° and 30.27°2θ) after incorporation into ACT films. The mechanical tests indicated the adequate integrity of the films and their resistance to bending. The morphological characterization showed JR19 crystals along with a homogeneously distributed porous structure throughout the surface of the films with an average diameter of 21.34 µm and 22.65 µm of the films alone and of those incorporating JR19F, respectively. This study was able to characterize the ACT films incorporating JR19, showing their potential to be further developed as wound healing dressings.
Collapse
Affiliation(s)
- Amaro César Lima de Assis
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Lívia Maria Coelho de Carvalho Moreira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Beatriz Patrício Rocha
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Milena Raissa Bezerra Pereira
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Demis Ferreira de Melo
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Ricardo Olímpio de Moura
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
| | - Eduardo Pereira de Azevedo
- Graduate Program of Biotechnology, Laureate International Universities–Universidade Potiguar (UnP), Natal 59056-000, Rio Grande do Norte, Brazil;
| | - João Augusto Oshiro-Junior
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| | - Bolívar Ponciano Goulart de Lima Damasceno
- Graduate Program in Pharmaceutical Sciences, Biological and Health Sciences Center, State University of Paraíba (UEPB), Av. Juvêncio Arruda, s/n, Bairro Universitário, Campina Grande 58429-600, Paraíba, Brazil; (A.C.L.d.A.); (L.M.C.d.C.M.); (B.P.R.); (M.R.B.P.); (D.F.d.M.); (R.O.d.M.)
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Biological and Health Sciences Center, State University of Paraíba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande 58429-600, Paraíba, Brazil
- Correspondence: (J.A.O.-J.); (B.P.G.d.L.D.); Tel.: +55-83-3315-3300 (ext. 3516) (B.P.G.d.L.D.)
| |
Collapse
|
4
|
de Assis KMA, da Silva Leite JM, de Melo DF, Borges JC, Santana LMB, Dos Reis MML, Moreira VM, da Rocha WRV, Catão RMR, Dos Santos SG, da Silva Portela A, de Sousa Silva SM, de Oliveira TKB, de Souza da Silveira JW, Pires EG, Nonaka CFW, Sanches FAC, de Lima Damasceno BPG. Bicontinuous microemulsions containing Melaleuca alternifolia essential oil as a therapeutic agent for cutaneous wound healing. Drug Deliv Transl Res 2020; 10:1748-1763. [PMID: 32924099 DOI: 10.1007/s13346-020-00850-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/28/2020] [Indexed: 10/23/2022]
Abstract
The Melaleuca alternifolia essential oil (MEO) has been widely used due to its healing and antimicrobial action. Its incorporation into drug delivery systems is a reality, and numerous studies have already been developed for this purpose. In this regard, the aim of this work was to develop, characterize, and evaluate the in vivo pharmacological activity of bicontinuous microemulsions (BME) containing MEO. Through diagram construction, a formulation consisting of Kolliphor® HS 15 (31.05%), Span® 80 (3.45%), isopropyl myristate (34.5%), and distilled water (31%) was selected and MEO was incorporated in the proportion of 3.45% (v/v). Morphological analysis characterization confirms that the system studied herein is a BME. The evaluated formulation showed physicochemical characteristics that allow its topical use. Rheologically, samples were characterized as pseudo-plastic non-Newtonian thixotropic fluids. The chromatographic method developed is in accordance with the current recommendations. The extraction method used assured a 100% recovery of the pharmacological marker (terpinen-4-ol). In vivo studies suggest that BME loaded with MEO may contribute to the healing process of skin wounds. In addition, it demonstrated antibacterial activity for Gram-positive and Gram-negative bacteria. Therefore, the BME system loaded with MEO is promising as a healing and antimicrobial agent for skin wounds.Graphical abstract.
Collapse
Affiliation(s)
- Karoll Moangella Andrade de Assis
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Joandra Maísa da Silva Leite
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Demis Ferreira de Melo
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Joyce Cordeiro Borges
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Lucas Matheus Barreto Santana
- Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Malu Maria Lucas Dos Reis
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Vandiara Martins Moreira
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Wilma Rainny Vieira da Rocha
- Laboratory of Microbiology, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | - Raïssa Mayer Ramalho Catão
- Laboratory of Microbiology, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | | | | | | | | | - João Walter de Souza da Silveira
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil
| | | | | | - Fátima Aparecida Castriani Sanches
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil.,Federal Institute of Education, Science and Technology Baiano, IFBA, Campus Catu, Catu, Bahia, Brazil
| | - Bolívar Ponciano Goulart de Lima Damasceno
- Graduate Program of Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Paraiba, Brazil. .,Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, State University of Paraíba (UEPB), Campina Grande, Paraiba, Brazil.
| |
Collapse
|